• Private placement of €1 million carried out with a restricted circle of Italian private and institutional investors
• Following the latest announcements, these funds will allow Ikonisys to accelerate its growth by continuing its commercial development in Europe and the United States with Hospitex and by supporting the implementation of the distribution agreement entered into with Biocare
Paris, December 28, 2023 – 6:00 p.m. CET – Ikonisys SA (ISIN Code: FR00140048X2 / Mnemonic: ALIKO), company specializing in the early and precise detection of cancer thanks to a unique and fully automated solution for medical diagnostic laboratories (the “ Issuer”), announces today that it has raised €1 million through a private placement with Italian private and institutional investors, in order to strengthen its financial resources for the implementation of the distribution agreement with Biocare Medical and future integration of Hospitalex International.